Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume
Takahiro Masuda, Shigeaki Muto, Keiko Fukuda, et al.
Physiological Reports (2020) Vol. 8, Iss. 2
Open Access | Times Cited: 101

Showing 26-50 of 101 citing articles:

Modern trends in diuretics development
Tetiana Titko, Lina Perekhoda, Іryna Drapak, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112855-112855
Closed Access | Times Cited: 35
Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease
Suyan Duan, Lu Fang, Dandan Song, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 29
Relationship of Dapagliflozin With Serum Sodium
Su Ern Yeoh, Kieran F. Docherty, Pardeep S. Jhund, et al.
JACC Heart Failure (2022) Vol. 10, Iss. 5, pp. 306-318
Open Access | Times Cited: 22
Dual SGLT1/SGLT2 inhibitor phlorizin reduces glucose transport in experimental peritoneal dialysis
Giedre Martus, Karin Bergling, Carl M. Öberg
Peritoneal Dialysis International (2022) Vol. 43, Iss. 2, pp. 145-150
Open Access | Times Cited: 20
SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure
Rahul Gupta, Theresa Maitz, David Egeler, et al.
Trends in Cardiovascular Medicine (2022) Vol. 33, Iss. 8, pp. 479-486
Closed Access | Times Cited: 20
Sex-Specific Computational Models of Kidney Function in Patients With Diabetes
Sangita Swapnasrita, Aurélie Carlier, Anita T. Layton
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 19
SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats
Takahiro Masuda, Ken Ohara, Volker Vallon, et al.
AJP Renal Physiology (2022) Vol. 323, Iss. 3, pp. F361-F369
Open Access | Times Cited: 19
Empagliflozin increases kidney weight due to increased cell size in the proximal tubule S3 segment and the collecting duct
Frederick Sinha, Anna Federlein, Annika Biesold, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Proximal versus distal diuretics in congestive heart failure
Massimo Nardone, Vikas S. Sridhar, Kevin Yau, et al.
Nephrology Dialysis Transplantation (2024) Vol. 39, Iss. 9, pp. 1392-1403
Open Access | Times Cited: 4
Sodium–Glucose Cotransporter 2 Inhibitor Combined with Conventional Diuretics Ameliorate Body Fluid Retention without Excessive Plasma Volume Reduction
Maki Asakura-Kinoshita, Takahiro Masuda, Kentaro Oka, et al.
Diagnostics (2024) Vol. 14, Iss. 11, pp. 1194-1194
Open Access | Times Cited: 4
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Kidney Disease and Beyond
Zein Alabdin Hannouneh, Carmen Elena Cervantes, Mohamad Hanouneh, et al.
Glomerular Diseases (2025) Vol. 5, Iss. 1, pp. 119-132
Open Access
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
Gilda M. Portalatin, Irene Hong‐McAtee, Anna Burgner, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access
The role of the clinical laboratory in diagnosing hyponatremia disorders
Kenrick Berend, Micah L. A. Heldeweg
Critical Reviews in Clinical Laboratory Sciences (2025), pp. 1-26
Closed Access
Progress in the Study of the Effect of SGLT2 Inhibitors on Glomerular Filtration Rate and Its Mechanism
立红 李
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 1654-1660
Closed Access
A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease
Lucia Del Vecchio, Angelo Beretta, Carlo Jovane, et al.
Drugs (2021) Vol. 81, Iss. 13, pp. 1491-1511
Closed Access | Times Cited: 26
The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet
Rosalie A. Scholtes, Marcel H.A. Muskiet, Michiel J.B. van Baar, et al.
Kidney International Reports (2022) Vol. 7, Iss. 5, pp. 1084-1092
Open Access | Times Cited: 18
Sodium–glucose cotransporter inhibition in polycystic kidney disease: fact or fiction
Barış Afşar, Rengin Elsürer Afşar, Atalay Demiray, et al.
Clinical Kidney Journal (2022) Vol. 15, Iss. 7, pp. 1275-1283
Open Access | Times Cited: 17
Update on Hypertension Research in 2021
Masaki Mogi, Tatsuya Maruhashi, Yukihito Higashi, et al.
Hypertension Research (2022) Vol. 45, Iss. 8, pp. 1276-1297
Open Access | Times Cited: 16
Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals
Shaoxun Wang, Feng Jiao, Jane J. Border, et al.
AJP Heart and Circulatory Physiology (2021) Vol. 322, Iss. 2, pp. H246-H259
Open Access | Times Cited: 23
Cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors in diabetic and nondiabetic patients
Boyang Xiang, Xiao-Ya Zhao, Xiang Zhou
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 21
SGLT2 Inhibitors in Management of Severe Hypomagnesemia in Patients Without Diabetes: A Report of 4 Cases
Chintan V. Shah, Nour Hammad, Bhavna Bhasin, et al.
Kidney Medicine (2023) Vol. 5, Iss. 9, pp. 100697-100697
Open Access | Times Cited: 9
2023 update and perspectives
Masaki Mogi, Atsushi Tanaka, Koichi Node, et al.
Hypertension Research (2023) Vol. 47, Iss. 1, pp. 6-32
Closed Access | Times Cited: 8
Sodium-glucose co-transporter-2 inhibitors: peculiar “hybrid” diuretics that protect from target organ damage and cardiovascular events
Riccardo Sarzani, Federico Giulietti, Chiara Di Pentima, et al.
Nutrition Metabolism and Cardiovascular Diseases (2020) Vol. 30, Iss. 10, pp. 1622-1632
Open Access | Times Cited: 22
Renal Tubular Handling of Glucose and Fructose in Health and Disease
Volker Vallon, Takahiko Nakagawa
Comprehensive physiology (2021), pp. 2995-3044
Open Access | Times Cited: 20
Sodium-Glucose Cotransporter-2 Inhibitors Improve Heart Failure with Reduced Ejection Fraction Outcomes by Reducing Edema and Congestion
M Vanegas Hernandez, Ryan D. Sullivan, Mariana E. McCune, et al.
Diagnostics (2022) Vol. 12, Iss. 4, pp. 989-989
Open Access | Times Cited: 13

Scroll to top